Case report: Medical cannabis-warfarin drug-drug interaction
Abstract Aim A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is described. Warfarin continues to be a cornerstone of anticoagulation treatment despite the recent addition of FDA-approved anticoa...
Saved in:
Main Authors: | Tyan F. Thomas (Author), Evdokia S. Metaxas (Author), Thu Nguyen (Author), Whitni Bennett (Author), Kathryn V. Skiendzielewski (Author), Diane H. Quinn (Author), Alice L. Scaletta (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of potential drug-drug interactions with medical cannabis
by: Jessie Jia Yi Ho, et al.
Published: (2024) -
Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020) -
Warfarin and Polypharmacy Challenges in Sudan: Drug Interactions in Patient Cohort
by: Omer AAA, et al.
Published: (2024) -
Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
by: Saaket Agrawal, et al.
Published: (2020) -
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
by: Rahul Nachnani, et al.
Published: (2024)